Family Care Hospitals Ltd – Sowmya Deshpande sells 184,383 shares, stake falls to 6.03%

What Family Care Hospitals announced

On 30 June 2026 the Bombay Stock Exchange received a disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The filing was submitted by Dr Sowmya Deshpande, who reported the sale of a portion of her voting shareholding in Family Care Hospitals Ltd (BSE: 516110).

"I have sold shares of Family Care Hospitals Ltd," the filing states, confirming the disposal of 184,383 voting shares.

The announcement does not involve any change in control, merger, or acquisition; it merely records a reduction in the shareholding of an individual investor.

Details of the share sale

The filing provides a granular breakdown of the transaction:

• Acquirer / Person Acting in Concert (PAC): Sowmya Deshpande.
• Mode of acquisition/sale: Open market.
• Sale period: 23 June 2026 to 29 June 2026.
• Number of shares sold: 184,383 voting shares.
• Percentage of total voting capital sold: 0.34%.
• Face value of each share: Rs 10.

Family Care Hospitals’ equity share capital before and after the transaction remained unchanged at Rs 54.01 crore, representing 5,40,14,774 shares.

Shareholding before and after the disposal

The filing lists the shareholder’s holdings both prior to and following the sale:

• Before sale: 3,443,519 voting shares, equivalent to 6.38% of the total voting capital.
• After sale: 3,259,136 voting shares, equivalent to 6.03% of the total voting capital.

The reduction of 184,383 shares therefore lowered Ms Deshpande’s stake by 0.35 percentage points.

Regulatory filing under SEBI Regulation 29(2)

Regulation 29(2) requires any person who acquires or disposes of shares that cross the 1% threshold of a listed company’s voting capital to disclose the transaction to the stock exchange within two working days. The filing satisfies this requirement by providing:

1. Name and contact details of the acquirer.
2. Whether the acquirer belongs to the promoter group (the answer is “No”).
3. Detailed numbers of shares held before, sold, and after the transaction.
4. The mode of transaction (open market) and the exact dates.
5. The total equity share capital of the target company.

No further approvals or shareholder meetings are required for this type of disposal, as it does not affect control or trigger any mandatory offer.

Key facts at a glance

Why this matters for investors

The disclosure is a routine compliance filing that informs the market about a change in the shareholding pattern of an individual investor. For existing shareholders, the key implications are:

• No dilution: The transaction involves a sale of existing shares; no new shares were issued, so the capital structure remains unchanged.
• Control unchanged: The holder’s post‑sale stake of 6.03% is well below any control thresholds, and the filing confirms she is not part of the promoter group.
• Transparency: The open‑market nature of the sale and the precise dates provide clarity on market activity and prevent speculation about hidden agreements.
• Liquidity signal: A modest sale by a sizable shareholder may indicate a personal liquidity need or portfolio rebalancing, but the filing does not disclose any strategic intent.

Investors can update their shareholding registers accordingly, but no further corporate actions (such as board approvals or shareholder meetings) are anticipated solely because of this disposal.

Conclusion

Family Care Hospitals Ltd has recorded the open‑market sale of 184,383 voting shares by Sowmya Deshpande, reducing her holding from 6.38% to 6.03% of the company’s equity. The filing, made on 30 June 2026, complies with SEBI Regulation 29(2) and does not trigger any change in control, dilution, or additional regulatory steps. The company’s capital structure and promoter composition remain unchanged.